Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVBOX: Vinorelbine and Oxaliplatin in Pretreated Metastatic TNBC
NCT01528826Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2011
- Primary completion
- Jul 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, oxaliplatin in triple negative breast cancer (TNBC), sponsored by Fudan University. Status: unknown.
02
Drugs
vinorelbineoxaliplatin
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01528826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528826.